期刊簡介預(yù)計(jì)審稿時(shí)間： 一般,3-6周 約8.8周

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.

BBA 疾病的分子基礎(chǔ) (BBA Molecular Basis of Disease) 致力于解決疾病過程和人類疾病模型的生物化學(xué)和分子遺傳學(xué)問題。該期刊涵蓋衰老、癌癥、代謝、神經(jīng)和免疫疾病等方面的內(nèi)容。特別鼓勵(lì)投稿專注于使用動物模型闡明每種疾病的生化和機(jī)制見解。稿件應(yīng)強(qiáng)調(diào)疾病途徑的潛在機(jī)制，并為理解和/或治療這些疾病提供新穎的貢獻(xiàn)。高度描述性和方法開發(fā)性投稿可能會在未經(jīng)全面審查的情況下被拒絕。強(qiáng)烈反對向 BBA - 疾病的分子基礎(chǔ) (BBA - Molecular Basis of Disease) 提交未經(jīng)邀請的評論，任何此類未經(jīng)邀請的評論都應(yīng)附上一封求職信，概述應(yīng)考慮該評論的令人信服的理由。

《Biochimica Et Biophysica Acta-molecular Basis Of Disease》(Biochimica Et Biophysica Acta-molecular Basis Of Disease)編輯部通訊方式為ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個(gè)人信息或稿件內(nèi)容。